Skip to main content
Top
Literature
1.
go back to reference Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine--update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum 45:341–350CrossRef Leung YY, Yao Hui LL, Kraus VB (2015) Colchicine--update on mechanisms of action and therapeutic uses. Semin Arthritis Rheum 45:341–350CrossRef
2.
go back to reference Dalbeth N, Lauterio TJ, Wolfe HR (2014) Mechanism of action of colchicine in the treatment of gout. Clin Ther 36:1465–1479CrossRef Dalbeth N, Lauterio TJ, Wolfe HR (2014) Mechanism of action of colchicine in the treatment of gout. Clin Ther 36:1465–1479CrossRef
4.
go back to reference Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271CrossRef Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 30:269–271CrossRef
5.
go back to reference Nakashima RA, Garlid KD (1982) Quinine inhibition of Na+ and K+ transport provides evidence for two cation/H+ exchangers in rat liver mitochondria. J Biol Chem 257:9252–9254PubMed Nakashima RA, Garlid KD (1982) Quinine inhibition of Na+ and K+ transport provides evidence for two cation/H+ exchangers in rat liver mitochondria. J Biol Chem 257:9252–9254PubMed
6.
go back to reference Cure E, Cumhur Cure M (2020) Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes Metab Syndr 14:405-406 Cure E, Cumhur Cure M (2020) Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis. Diabetes Metab Syndr  14:405-406
7.
go back to reference Sakai H, Mohri H, Borisy GG (1982) Biological functions of microtubules and related structures. Academic Press, Tokyo, New York Sakai H, Mohri H, Borisy GG (1982) Biological functions of microtubules and related structures. Academic Press, Tokyo, New York
8.
go back to reference Simon S, Roy D, Schindler M (1994) Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci U S A 91:1128–1132CrossRef Simon S, Roy D, Schindler M (1994) Intracellular pH and the control of multidrug resistance. Proc Natl Acad Sci U S A 91:1128–1132CrossRef
9.
go back to reference Costa-Pessoa JM, Figueiredo CF, Thieme K, Oliveira-Souza M (2013) The regulation of NHE1 and NHE3 activity by angiotensin II is mediated by the activation of the angiotensin II type I receptor/phospholipase C/calcium/calmodulin pathway in distal nephron cells. Eur J Pharmacol 721:322–331CrossRef Costa-Pessoa JM, Figueiredo CF, Thieme K, Oliveira-Souza M (2013) The regulation of NHE1 and NHE3 activity by angiotensin II is mediated by the activation of the angiotensin II type I receptor/phospholipase C/calcium/calmodulin pathway in distal nephron cells. Eur J Pharmacol 721:322–331CrossRef
10.
go back to reference Wagner CA, Giebisch G, Lang F, Geibel JP (1998) Angiotensin II stimulates vesicular H+-ATPase in rat proximal tubular cells. Proc Natl Acad Sci U S A 95:9665–9668CrossRef Wagner CA, Giebisch G, Lang F, Geibel JP (1998) Angiotensin II stimulates vesicular H+-ATPase in rat proximal tubular cells. Proc Natl Acad Sci U S A 95:9665–9668CrossRef
11.
go back to reference Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838–14843CrossRef Vickers C, Hales P, Kaushik V, Dick L, Gavin J, Tang J, Godbout K, Parsons T, Baronas E, Hsieh F, Acton S, Patane M, Nichols A, Tummino P (2002) Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838–14843CrossRef
12.
go back to reference Entzian P, Schlaak M, Seitzer U, Bufe A, Acil Y, Zabel P (1997) Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung 175:41–51CrossRef Entzian P, Schlaak M, Seitzer U, Bufe A, Acil Y, Zabel P (1997) Antiinflammatory and antifibrotic properties of colchicine: implications for idiopathic pulmonary fibrosis. Lung 175:41–51CrossRef
13.
go back to reference Maurizi M, Delorme N, Laprévote-Heully MC, Lambert H, Larcan A (1986) Acute respiratory distress syndrome in adults in colchicine poisoning. Ann Fr Anesth Reanim 5:530–532CrossRef Maurizi M, Delorme N, Laprévote-Heully MC, Lambert H, Larcan A (1986) Acute respiratory distress syndrome in adults in colchicine poisoning. Ann Fr Anesth Reanim 5:530–532CrossRef
14.
go back to reference Ben-Chetrit E (2019) Colchicine. In: Hashkes P, Laxer R, Simon A (eds) Textbook of autoinflammation. Springer, Cham Ben-Chetrit E (2019) Colchicine. In: Hashkes P, Laxer R, Simon A (eds) Textbook of autoinflammation. Springer, Cham
Metadata
Title
Colchicine may not be effective in COVID-19 infection; it may even be harmful?
Authors
Medine Cumhur Cure
Adem Kucuk
Erkan Cure
Publication date
01-07-2020
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 7/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05144-x

Other articles of this Issue 7/2020

Clinical Rheumatology 7/2020 Go to the issue